MEDICAL TECHNOLOGY
Untitled Page
Aliso Viejo’s Cianna Medical completes funding round for SAVI
The funding is slated to expediate its proprietary SAVI technology for breast cancer brachytherapy to market.
By Susan BelknappPublished: April 07, 2009 10:08 AM
Cianna Medical Inc. announced Tuesday that it has successfully completed a funding round totaling more than $10 million.
The medical device company specializes in women’s health and is committed to developing innovative treatments of early-stage breast cancer.
Emergent Medical Partners, Saints Capital, Mitsubishi International Corporation, and Fog City Fund (an initial investor in BioLucent), plus several private individuals participated in the funding round.
“Our ability to raise money from knowledgeable, highly regarded investors, despite the challenging economic environment, is further evidence that SAVI is a breakthrough technology,” says Jill Anderson, president and CEO of Cianna. “Cianna’s mission is to make the benefits of breast brachytherapy available to more women. It’s gratifying to achieve this goal thanks to the strength of our technology and because of SAVI’s increasingly broad acceptance among radiation oncologists, surgeons and patients.”
NEXT PAGE >>
Related headlines
Tustin’s Toshiba Medical: ONE for design excellence
Orange’s St. Joseph Health System among world’s greatest places to work
Aliso Viejo’s TechSpace, OCTANEe showcase innovation
"OC METRO Minute," April 3: American Red Cross of O.C. hosts Super CPR Day
"OC METRO Minute," April 2: UCI finds hormone suppression limits cocaine cravings
|
||||
|
Cianna Medical Inc. announced Tuesday that it has successfully completed a funding round totaling more than $10 million. The medical device company specializes in women’s health and is committed to developing innovative treatments of early-stage breast cancer. Emergent Medical Partners, Saints Capital, Mitsubishi International Corporation, and Fog City Fund (an initial investor in BioLucent), plus several private individuals participated in the funding round. “Our ability to raise money from knowledgeable, highly regarded investors, despite the challenging economic environment, is further evidence that SAVI is a breakthrough technology,” says Jill Anderson, president and CEO of Cianna. “Cianna’s mission is to make the benefits of breast brachytherapy available to more women. It’s gratifying to achieve this goal thanks to the strength of our technology and because of SAVI’s increasingly broad acceptance among radiation oncologists, surgeons and patients.” NEXT PAGE >> Related headlines Tustin’s Toshiba Medical: ONE for design excellence Orange’s St. Joseph Health System among world’s greatest places to work Aliso Viejo’s TechSpace, OCTANEe showcase innovation "OC METRO Minute," April 3: American Red Cross of O.C. hosts Super CPR Day "OC METRO Minute," April 2: UCI finds hormone suppression limits cocaine cravings |
||||
